
Aurinia Pharmaceuticals (AUPH) Earnings Dates & Reports
Aurinia Pharmaceuticals (AUPH) Most Recent Earnings
Report DateMay 12, 2025
Period EndingQ1 2025
Est. EPS$0.10
Actual EPS$0.16
EarningsBeat
Aurinia Pharmaceuticals (AUPH) Earnings
View the latest Aurinia Pharmaceuticals (AUPH) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in Aurinia Pharmaceuticals (AUPH)
Order type
Buy in
Order amount
Est. shares
0 shares
Aurinia Pharmaceuticals (AUPH) Earnings per Share (EPS) History
Signup for full accessBrowse free
Aurinia Pharmaceuticals (AUPH) Latest Earnings
The value each AUPH share was expected to gain vs. the value each share gained.
Aurinia Pharmaceuticals (AUPH) reported its most recent earnings on May 12, 2025 for Q1 2025, posting earnings per share (EPS) of $0.16. This exceeded analysts' expectations of $0.10 by 60.00%, marking a Beat.
For comparison, Aurinia Pharmaceuticals reported EPS of -$0.03 in the same quarter last year.
The company is expected to announce its next earnings report on 07/31/2025, with analysts projecting an EPS of $0.14.
Aurinia Pharmaceuticals (AUPH) Earnings History
Earnings | Est. EPS | Actual EPS | Surprise | |
---|---|---|---|---|
Q2 2025Jul 31, 2025 | $0.14 | Next earnings call Jul. 31, 2025 | ||
Q1 2025May 12, 2025 | $0.10 | $0.16 | +60.00% | |
Q4 2024Feb 27, 2025 | -$0.02 | $0.01 | -150.00% | |
Q3 2024Nov 7, 2024 | $0.01 | $0.10 | +900.00% | |
Q2 2024Aug 1, 2024 | $0.01 | $0.01 | 0.00% | |
Aurinia Pharmaceuticals (AUPH) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the Aurinia Pharmaceuticals’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
Report date | Price 1D before | Price 1D after | Change |
---|---|---|---|
May 12, 2025 | — | — | — |
Feb 27, 2025 | — | — | — |
Nov 7, 2024 | — | — | — |
Aug 1, 2024 | — | — | — |
Aurinia Pharmaceuticals (AUPH) Earnings FAQs
Aurinia Pharmaceuticals (AUPH) last reported earnings on May 12, 2025 for Q1 2025, posting an EPS of $0.16, which Beat the estimate of $0.10 by 60.00%.
For Q1 2025, Aurinia Pharmaceuticals (AUPH) reported an EPS of $0.16, exceeding analysts' estimate of $0.10 by 60.00%.
For Q1 2025, Aurinia Pharmaceuticals (AUPH) Beat expectations with an actual EPS of $0.16 vs. an estimated EPS of $0.10.
Following the last earnings report on May 12, 2025, Aurinia Pharmaceuticals (AUPH)'s stock price moved — from — to —.
The next Aurinia Pharmaceuticals (AUPH) earnings call is scheduled for Jul. 31, 2025, where executives will discuss financial results and outlook.